Navigation Links
Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, To Take Medical Leave and Appointment of Richard Markham as Chairman of the Board
Date:2/27/2008

PALATINE, Ill., Feb. 27 /PRNewswire-FirstCall/ -- Acura Pharmaceuticals, Inc. (Nasdaq: ACUR) announced that President and Chief Executive Officer Andy Reddick has begun a leave of absence for health reasons for an as-yet undetermined period. Mr. Reddick will continue to serve as a member of the Company's Board of Directors. At the same time, the Company announced that Richard Markham has been appointed to serve as non-executive Chairman of the Board. Mr. Markham has been a member of our Board of Directors since May, 2006. Since November 2004 Mr. Markham has served as a partner at Care Capital, LLC, a venture capital firm that primarily invests in life sciences companies. From May 2002 until August 2004, Mr. Markham was the Vice Chairman of the Management Board and Chief Operating Officer of Aventis SA. From December 1999 until May 2002 he was the Chief Executive Officer of Aventis Pharma AG. Previously he was the Chief Executive Officer of Hoechst Marion Roussel, the President and Chief Operating Officer of Marion Merrell Dow, Inc. and a member of its board of directors. From 1973 to 1993 Mr. Markham was associated with Merck & Co. Inc., culminating in his position as President and Chief Operating Officer.

The Company's Board of Directors, management and staff all wish Mr. Reddick a full and speedy recovery and look forward to his return as soon as possible.

About Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in research, development and manufacture of innovative Aversion(R) (abuse deterrent) Technology and related product candidates.

Forward Looking Statements

This press release contains "forward-looking statements" as defined in the Private Securi
'/>"/>

SOURCE Acura Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acuras Aversion(R) (Abuse-Deterrent) Technology
2. Acura Pharmaceuticals, Inc. Announces Implementation of Reverse Stock Split and New Trading Symbol: ACPH
3. Acura Pharmaceuticals, Inc. Announces Appointment of George K. Ross as Director
4. Acura Pharmaceuticals, Inc. Announces Approval to List Shares on NASDAQ and Effective Feb. 4, 2008 a New Trading Symbol: ACUR
5. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
9. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
10. ACG Announces Major Gift by Salix Pharmaceuticals, Inc.
11. Anthera Pharmaceuticals, Inc. Appoints Donald Santel to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...ire/ -- The Holiday,Stationstore at 2660 Eagan Woo...duce the price of E85 by a dollar a gallon on Wedn...promotion is timed to occur during the,Republican ...l vehicles,General Motors has made available to RN... per flexible fuel vehicle., The event also celeb...
(Date:8/29/2008)...Benefit Muscular Dystrophy Research , ... Students, faculty and staff from http://www.sbin..., raised $11,000 for muscular dystrophy research i...m the event are in support of local non-profit ww...r event was attended by more than 100 walkers, rep...
(Date:8/29/2008)..., - MYA Cosmetic Surgery Seems to be the Provider...g Question is who Will be Next?, Months of consta...al,television for an hour each night can have a ma... For many previous Big Brother contestants this ha...ants may undoubtedly spend,hours watching past foo...
(Date:8/29/2008)...dicine Encounter Management Systems (TEMS) to Demo...ble solution to national health care problems. , ...ugust 29, 2008 -- If there has been any one consis...atic National Convention it has been the party pla...re issues., , ,Our Democratic leadership recognize...
Breaking Medicine News(10 mins):Health News:An 'Unconventional' Fuel at an Unbelievable Price: Minnesota Station Cuts Cost of E85 by $1 Per Gallon 2Health News:Sanford-Brown Institute - Iselin Raises $11,000 for Ryan's Quest 2Health News:MYA Makes Big Brother Stars Amazing! 2Health News:MYA Makes Big Brother Stars Amazing! 3Health News:AMD Global Telemedicine Inc. Invited to Attend Democratic National Convention 2
...that one third of our lifetime is spent in sleep. ...n the quantity. A new study conducted reveals the ... over age 50. // And the mail villain held respons... been conducted among a group of 1003 adults by th...
...ay have taste sensors dedicated to detecting fat, ...foods. The study, which appears in the November i...uggests that rats and mice exhibit a spontaneous a...aises the possibility that an orosensory system is...
...ers do not treat patients with prostate cancer wit...th correct diagnosis and treatment options.// The ...rostate cancer and the study results showed that m...diagnosis insensitively. The Prostate Cancer Char...
...red in the South Asian feature in Times Magazine’s...s have put in their sincere efforts towards reduci...ion of a n innovative program. // Abhay Bang and ...iety for Education, Action and Research in Communi...
Other Medicine News:Health News:Lack of adequate sleep among people over 50 2Health News:Discovery of a built-in 'fat sensor' 2Health News:Prostate cancer patients not happy with health providers 2
(Date:8/25/2008)...eatment and Japanese Development Studies ...k, August 25 /- Genmab has,...b in chronic lymphocytic,leukemia and non-Hodgkin,...y plans to begin four studies of,ofatumumab in chr...-Hodgkin,s lymphoma (NHL) this year., "Genmab and...
(Date:8/22/2008)...RNewswire/ --, - Dangerous Bacteria Infect Three ...mething well-tried can also be innovative: already...ry antimicrobial. This,ability is now playing an i...spital germs. In a worldwide noted field test, a w...sbek in Hamburg, Germany, was equipped with,door h...
(Date:8/21/2008)...aign Addresses Knowledge Gap, Educates, Americans...nt Choice to Make this... A new survey of parents of,eight-to-17-year olds ...ings they believe they can do to help protect agai...idelines state that getting an annual flu,vaccinat...
(Date:8/21/2008)...wswire-USNewswire/ -- Dangerous disease,often spre.... To remedy,that, researchers at Kansas State Univ...om days down to hours., Sanjeev Narayanan, assist...ologist, both in the department of diagnostic medi...potted microarray to seek out the,specific genetic...
Breaking Medicine Technology:Genmab Announces Upcoming Ofatumumab Studies 2Genmab Announces Upcoming Ofatumumab Studies 3Genmab Announces Upcoming Ofatumumab Studies 4Copper Eliminates Resistant Hospital Germs in a Worldwide Field Test 2Copper Eliminates Resistant Hospital Germs in a Worldwide Field Test 3Survey Shows Parents' Best Intentions Out of Step with Expert Recommendations in Protecting Kids from Flu 2Survey Shows Parents' Best Intentions Out of Step with Expert Recommendations in Protecting Kids from Flu 3Survey Shows Parents' Best Intentions Out of Step with Expert Recommendations in Protecting Kids from Flu 4Survey Shows Parents' Best Intentions Out of Step with Expert Recommendations in Protecting Kids from Flu 5Rapid Test for Pathogens Developed By K-State Researchers Could Be Used to Detect Diseases Used By Bioterrorists 2Abbott Named One of the Best Companies for Hispanics by Hispanic Business Magazine 3306 1Abbott Named One of the Best Companies for Hispanics by Hispanic Business Magazine 3306 2Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 1Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 2Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 3Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 4Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 5Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 6Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 7Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 8Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 9Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 10Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 11Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 12Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 13Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 14Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 15Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 16Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 17Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 18Arena Pharmaceuticals to Report Third Quarter 2007 Financial Results and to Host Conference Call and Webcast on Wednesday October 17 2007 1174 1Arena Pharmaceuticals to Report Third Quarter 2007 Financial Results and to Host Conference Call and Webcast on Wednesday October 17 2007 1174 2Arena Pharmaceuticals to Report Third Quarter 2007 Financial Results and to Host Conference Call and Webcast on Wednesday October 17 2007 1174 3Hypertension Triples Womens Diabetes Risk 3304 1Hypertension Triples Womens Diabetes Risk 3304 2
...ine-urea derivative compound series,show highly se...r,cancer treatment, QUEBEC, April 16, 2007 /PRNews..., pure play biopharmaceutical company focused on,e...abstract,outlining first in vitro data on its pyri...I3K inhibition, at the American,Association for Ca...
...er Patients With Improved Potential to,Battle Thei...swire/ -- Insert,Therapeutics, Inc., a majority-ow...nnounced today its novel delivery system,called Cy...ion at,the 2007 American Association for Cancer Re...poster includes new research findings,on a promisi...
Other Medicine Technology:AEterna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 2AEterna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 3Poster on Cyclosert Drug Delivery Presented at AACR Meeting 2Poster on Cyclosert Drug Delivery Presented at AACR Meeting 3Poster on Cyclosert Drug Delivery Presented at AACR Meeting 4
...ce the finest surgical-quality loupes available a...for innovative optical design, combining superior ...g optimum performance with maximum comfort, SheerV...essionals worldwide. All SheerVision loupes come c...
...ce the finest surgical-quality loupes available a...for innovative optical design, combining superior ... optimum performance with maximum comfort, SheerVi...ssionals worldwide. Make both a professional and a...
...ce the finest surgical-quality loupes available a...for innovative optical design, combining superior ... optimum performance with maximum comfort, SheerVi...ssionals worldwide. All SheerVision loupes come co...
...ion manufactures its signature line of award-winni...ightweight, yet durable titanium frame. These next...on razor-sharp clarity, an ultra-lightweight desi...-fog, and scratch resistance. With SheerVision fl...
Medicine Products: